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A B S T R A C T
background: Classical electrocardiographic (ECG) criteria for left ventricular hypertrophy (LVH) are well 
studied in older populations and patients with hypertension. Their utility in young pre-participation 
cohorts is unclear. 
Aims: We aimed to develop machine learning models for detection of echocardiogram-diagnosed LVH 
from ECG, and compare these models with classical criteria. 
Methods: Between November 2009 and December 2014, pre-participation screening ECG and subse-
quent echocardiographic data was collected from 17 310 males aged 16 to 23, who reported for medical 
screening prior to military conscription. A final diagnosis of LVH was made during echocardiography, 
defined by a left ventricular mass index >115 g/m2. The continuous and threshold forms of classical ECG 
criteria (Sokolow–Lyon, Romhilt–Estes, Modified Cornell, Cornell Product, and Cornell) were compared 
against machine learning models (Logistic Regression, GLMNet, Random Forests, Gradient Boosting 
Machines) using receiver-operating characteristics curve analysis. We also compared the important 
variables identified by machine learning models with the input variables of classical criteria.
Results: Prevalence of echocardiographic LVH in this population was 0.82% (143/17310). Classical ECG 
criteria had poor performance in predicting LVH. Machine learning methods achieved superior perfor-
mance: Logistic Regression (area under the curve [AUC], 0.811; 95% confidence interval [CI], 0.738–0.884), 
GLMNet (AUC, 0.873; 95% CI, 0.817–0.929), Random Forest (AUC, 0.824; 95% CI, 0.749–0.898), Gradient 
Boosting Machines (AUC, 0.800; 95% CI, 0.738–0.862). 
Conclusions: Machine learning methods are superior to classical ECG criteria in diagnosing echocar-
diographic LVH in the context of pre-participation screening. 
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Left ventricular hypertrophy (LVH) is a clinically significant 
condition where there is an increased thickness of the left 
ventricular wall. It may be secondary to conditions such as 
athlete’s heart, hypertension, valvular heart disease, and hy-
pertrophic cardiomyopathy [1]. These conditions may need 
further evaluation, and may adversely impact fitness for 
participation in athletic endeavours and military training. 
Various electrocardiographic (ECG) criteria (Sokolow–Lyon 
[2], Cornell [3] etc.) have been proposed as markers of LVH, 
and are well studied in Western populations, particularly in 
hypertensive patients [4]. In our study, we examined ECG 
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W h A T ’ S  N E W ?
This large retrospective study examined the utility of machine learning algorithms in detecting echocardiographic left ventricular 
hypertrophy, when applied to screening electrocardiograms (ECG) of a young pre-participation cohort. Classical ECG criteria 
are not recommended in these individuals due to poor correlation with anatomic pathology, and no alternative algorithms 
currently exist. The machine learning algorithms applied showed good predictive power and performed better than classical 
criteria, whether clinical and anthropometric data were included as predictors or not. They also identified as important less 
recognized ECG parameters predictive of left ventricular hypertrophy, such as the mean QT interval, mean QRS duration, and 
R wave in lead I.
LVH criteria as predictors of LVH detected on transthoracic 
echocardiography, as defined by a left ventricular mass 
index (LVMI) >115 g/m2.
Since 2008, it has been recognized that isolated electro-
cardiographic LVH may not apply to young athletic cohorts 
[5], and no specific recommendation exists for pre-partici-
pation cohorts. Referral for further cardiac investigations is 
no longer recommended by subsequent guidelines, such 
as the European Society of Cardiology (ESC) 2010 criteria 
[6], Seattle Criteria (2013) [7], Refined Criteria (2014) [8] 
and most recently the International Criteria for ECG inter-
pretation in Athletes (2017) [9]. This was based on data 
showing no correlation between positive ECG LVH criteria 
and actual pathological LVH on cardiac imaging [10]. Never-
theless, detection of actual anatomic LVH remains a clinical 
outcome of interest. This is especially so in the context of 
fitness certification before participation in military training 
or sport, where patients with pathologic conditions (e.g. 
hypertrophic cardiomyopathy) should be excluded [11].
The main limitation of classical ECG criteria (e.g. 
Sokolow–Lyon, Cornell, Romhilt–Estes) is low sensitivity 
overall [4], and more so in younger populations [12]. 
This may stem from their statistical formulation, as most 
classical models assume each predictive factor is related 
in a linear fashion to LVH. For example, the Sokolow–Lyon 
criteria involve direct summation of S wave height in V1, 
plus the larger of the R wave height in V5 or V6. This is an 
oversimplification of the overall information contained in 
an ECG. In addition, most current ECG criteria for LVH do not 
take into account demographic parameters, such as age, 
or anthropometric parameters, such as body mass index, 
body fat percentage, and presence of pectus excavatum.
Machine learning, or artificial intelligence, is an alter-
native approach that may improve the prediction of true 
LVH based on ECG parameters [13]. It can identify complex 
relationships between predictive parameters, and com-
bine these in a non-linear fashion. This has the potential 
to improve prediction of clinical outcomes, and has been 
studied elsewhere for outcomes such as cardiovascular 
risk prediction [14]. There is limited literature on machine 
learning techniques to predict LVH from ECG parameters 
in adult cohorts [15, 16], but none in younger pre-partic-
ipation cohorts. 
Our objective in this study was to develop machine 
learning algorithms to predict LVH from resting ECG, as 
well as routine demographic, clinical, and anthropometric 
data in a cohort of young pre-participation individuals. All 
machine learning models were compared to classical ECG 
criteria for LVH. Machine learning models were first trained 
on ECG data alone, for a fair comparison with classical ECG 
criteria (which do not contain anthropometric data). They 
were also separately trained on the full set of predictors, 
including all ECG, demographic, clinical, and anthropomet-




The Singapore Armed Forces have conducted universal 
pre-participation screening before military enlistment for 
all young male Singaporeans [17]. Universal ECG screening 
was implemented since 2008, based on an Italian pre-par-
ticipation cardiovascular screening system proposed by 
Corrado et al. [18], with referral for echocardiography if 
Sokolow–Lyon criteria for LVH were met. Echocardiography 
was performed within a year of referral to the national 
cardiology tertiary center, with all studies reported by 
a cardiology specialist. Our patient population comprised 
of 17 310 prospective male military recruits who had un-
dergone transthoracic echocardiography from November 
2009 to December 2014, as part of determination of their 
fitness to enlist into military service. 
Approval for collection and use of data was granted by 
the Singapore Armed Forces Joint Medical Committee, and 
ethical approval was obtained from the local institutional 
review board. 
Variables
For all individuals, demographic, anthropometric, and 
clinical parameters were collected, as well as a baseline 
resting 12 lead ECG. Resting ECGs were performed by 
trained personnel using the Philips Pagewriter TC70 ECG 
machine, which recorded at a sampling rate of 500 Hz. The 
electronic ECG readouts were analyzed using a proprietary 
Philips TM TraceMasterVue modular ECG analysis system 
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with automatic measurement of the ECG parameters. The 
full list of parameters collected are included in Supplemen-
tary material, Table S1.
The primary outcome was LVH, as assessed by LVMI on 
transthoracic echocardiography. Echocardiographic assess-
ment was used as the determinant in view of operational 
considerations precluding general use of advanced imag-
ing (such as cardiac magnetic resonance imaging [CMRI]) or 
histological diagnosis. A cutoff of LVMI >115 g/m2 was used 
in this male population, based on the American Society of 
Echocardiography guidelines [19].
Prediction algorithms
For the machine learning algorithms, we employed 
a 70:30 train-test split (i.e. using 70% of the data to train the 
machine learning model, and the remaining 30% to assess 
accuracy). Continuous variables were scaled and normal-
ized. Fivefold cross validation was used to tune the model 
parameters. We implemented some commonly used types 
of supervised machine-learning algorithms. We included 
regression based methods, namely conventional Logistic 
Regression and GLMNet (penalized logistic regression with 
the ElasticNet penalty) [20], as well as tree based methods, 
which were Random Forests [21] and Gradient Boosting 
Machines [22]. All machine learning models were trained 
first on ECG parameters only, and separately on the full set 
of predictive parameters (including demographic, clinical, 
and anthropometric data). 
The machine learning models were compared with 
classical ECG criteria. We examined the commonly used 
Sokolow–Lyon, Romhilt–Estes, Modified Cornell, Cornell 
Product, and Cornell methods for assessing LVH on ECG, 
and calculated both their continuous and threshold 
forms. We summarize the different classical criteria being 
compared in Supplementary material, Table S2.
Statistical analysis
Summary statistics for anthropometric and ECG parameters 
were calculated, including counts and proportions for cat-
egorical data, as well as medians and interquartile ranges 
for continuous data.
The performance of the machine learning algorithms 
was assessed using the test cohort. We calculated receiver 
operating characteristic (ROC) curves for each algorithm, as 
well as the area under the curve (AUC). The 95% confidence 
interval (CI) for each AUC was determined using a bootstrap 
method. Likewise, we calculated the ROC and AUCs for the 
continuous versions of the various classical ECG meth-
ods. For machine learning models, variable importance was 
assessed using the final tuned coefficients for regression 
based models, and using the weighted average improve-
ment in node impurity for tree based models. Analysis was 
performed using RStudio with R version 3.6.1, and using the 
packages caret, glmnet, randomForest, and pROC. 
RESulTS
Study population characteristics
Our study included a total of 17 310 young men aged 16 to 
23 years, of which 143 (0.82%) had LVH. The characteristics 
of the population stratified by LVH status are included in 
Table 1. Categorical variables are tabulated as frequencies 
with their respective percentages, and continuous variables 
are tabulated as means with standard deviation.
Performance of the various models
The predictive accuracy of the classical and machine 
learning models was assessed by the AUC. The values 
for the various models are tabulated in Table 2, with the 
bootstrapped 95% CIs. Other evaluation parameters are 
tabulated in Supplementary material, Table S3.
All machine learning models showed superior predic-
tive accuracy compared to classical models, regardless 
of whether electrocardiographic (ECG) parameters alone 
were considered, or if all available predictive parameters 
were included. In particular, GLMNet, Random Forests, and 
Logistic Regression had excellent predictive accuracy with 
AUC surpassing 0.8. This can be seen in the numerical AUC 
values, as well as the ROC plots in Figure 1. The machine 
learning models which included ECG parameters only 
performed similarly to those with all predictive parameters 
included, as evidenced by the numerically similar AUC 
values as well as the overlapping 95% CIs.
Important variables
To interpret the machine learning models and compare 
them to classical criteria, the top ten most important var-
iables for each machine learning model were ranked and 
listed in Table 3. Weight, height, body fat percentage, and 
systolic blood pressure were anthropometric parameters 
not used in the classical ECG criteria, but were deemed 
important to the machine learning algorithms. Mean QT 
interval, mean QRS duration and R wave in lead I were 
ECG parameters not used in the classical criteria, but were 
deemed important to the machine learning algorithms, 
both when ECG parameters alone were included, and when 
all predictive parameters were included.
dISCuSSION
General discussion
To the best of our knowledge, this is one of the few studies 
to employ machine learning to detect LVH. In our large, 
pre-participation cohort, we found that all 4 machine 
learning algorithms tested were superior to classical ECG 
criteria in identifying echocardiographic LVH. The high AUC 
values [23] of above 0.8 derived from the machine learning 
models are excellent and at a level which would generally 
be acceptable for clinical use. Other classical algorithms 
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Table 1. Population characteristics stratified by left ventricular hypertrophy (LVH) status
variables Overall (n = 17 310) No lvH (n = 17 167) Presence of lvH (n = 143)
Demographic and anthropometric parameters
Age, years 18.0 (17.0–19.0) 18.0 (17.0–19.0) 18.0 (17.0–19.0)
Smoking 2921 (17) 2898 (17) 23 (16)
Urine dipstick blood (present) 33 (0) 33 (0) 0 (0)
Urine dipstick glucose (present) 28 (0) 28 (0) 0 (0)
Urine dipstick protein (present) 19 (0) 19 (0) 0 (0)
Pectus excavatum (present) 139 (1) 139 (1) 0 (0)
Hemoglobin, g/dl 15.6 (14.9–16.2) 15.6 (15.0–16.2) 15.3 (14.7–15.8)
Height, cm 172 (168–177) 172 (168–177) 172 (168–176)
Weight, kg 61 (54.5–69.5) 61 (54.5–69.4) 68 (60.4–75.35)
Body fat percentage, % 18.2 (14.5–23) 18.2 (14.5–23) 20.1 (17.3–24.3)
Systolic blood pressure, mm Hg 115 (105–125) 115 (105–125) 117 (108–127)
Diastolic blood pressure, mm Hg 66 (58–73) 66 (58–73) 64 (57–71)
Electrocardiogram parameters
Mean PR interval, ms 144 (132–157) 144 (132–157) 148 (136.5–160.5)
Mean PR segment, ms 41 (31–51) 41 (31–51) 44 (33.5–54)
Mean QRS duration, ms 95 (89–102) 95 (89–102) 98 (92–105.5)
Mean QTc interval, ms 410 (395–425) 410 (395–425) 411 (394–427)
Mean QT interval, ms 364 (345–385) 364 (345–385) 388 (360.5–415.5)
Mean ventricular rate, bpm 43 (28–76) 43 (28–76) 54 (32–99.5)
QT interval dispersion, ms 76 (66–87) 76 (66–87) 68 (58–78)
R wave height in aVF, mV 1.4 (0.8–1.9) 1.4 (0.8–1.9) 1.6 (0.9–2.1)
R wave height in aVL, mV 0.2 (0.1–0.2) 0.2 (0.1–0.2) 0.2 (0.1–0.4)
R wave height in aVR, mV 0.1 (0.1–0.3) 0.1 (0.1–0.3) 0.1 (0–0.2)
R wave height in I, mV 0.5 (0.3–0.7) 0.5 (0.3–0.7) 0.7 (0.4–0.9)
R wave height in II, mV 1.5 (1–2.1) 1.5 (1–2.1) 1.9 (1.2–2.3)
R wave height in III, mV 1.2 (0.7–1.8) 1.2 (0.7–1.8) 1.3 (0.6–1.9)
R wave height in V1, mV 0.3 (0.2–0.5) 0.3 (0.2–0.5) 0.4 (0.2–0.5)
R wave height in V2, mV 0.7 (0.5–1) 0.7 (0.5–1) 0.8 (0.6–1.1)
R wave height in V3, mV 1 (0.7–1.4) 1 (0.7–1.4) 1.2 (0.9–1.6)
R wave height in V4, mV 1.8 (1.3–2.4) 1.8 (1.3–2.4) 2.3 (1.6–2.9)
R wave height in V5, mV 1.8 (1.3–2.3) 1.8 (1.3–2.2) 2.2 (1.6–2.6)
R wave height in V6, mV 1.4 (1–1.8) 1.4 (1–1.8) 1.7 (1.3–2)
S wave depth in aVF, mV 0.1 (0–0.3) 0.1 (0–0.3) 0.1 (0–0.3)
S wave depth in aVL, mV 0.5 (0.2–0.8) 0.5 (0.2–0.8) 0.5 (0.2–0.9)
S wave depth in aVR, mV 0 (0–1.1) 0 (0–1.1) 0 (0–1.4)
S wave depth in I, mV 0.2 (0.1–0.4) 0.2 (0.1–0.4) 0.2 (0–0.3)
S wave depth in II, mV 0.2 (0–0.3) 0.2 (0–0.3) 0.1 (0–0.3)
S wave depth in III, mV 0.1 (0–0.2) 0.1 (0–0.2) 0.1 (0–0.3)
S wave depth in V1, mV 1.1 (0.6–1.5) 1.1 (0.6–1.5) 1.3 (0.8–1.8)
S wave depth in V2, mV 1.7 (1.1–2.3) 1.7 (1.1–2.3) 1.8 (1.4–2.7)
S wave depth in V3, mV 1.5 (1.0–2.0) 1.5 (1.0–2.0) 1.6 (1.1–2.3)
S wave depth in V4, mV 0.6 (0.3–1.0) 0.6 (0.3–1.0) 0.7 (0.4–1.1)
S wave depth in V5, mV 0.3 (0.1–0.5) 0.3 (0.1–0.5) 0.3 (0.1–0.5)
S wave depth in V6, mV 0.1 (0–0.3) 0.1 (0–0.3) 0.1 (0–0.3)
Ventricular activation time in aVL, ms 31 (20–62) 31 (20–62) 34 (22–60)
Ventricular activation time in V5, ms 44 (37–49) 44 (37–49) 47 (39–51)
Ventricular activation time in V6, ms 44 (38–48) 44 (38–48) 47 (42–52)
Values are expressed as counts (percentages) or median (interquartile range) as appropriate
based on ECG data were less discriminatory and had a lower 
predictive accuracy for LVH. 
The machine learning models identified non-traditional 
ECG parameters that had predictive value for LVH. The 
approaches of the machine learning models were mathe-
matically different, with Logistic Regression and GLMNet 
being regression type models, whereas Random Forest 
and Gradient Boosting Machines were decision tree-based 
models. We noted that some parameters that are less rec-
ognized and/or not included in all classical models, were 
instead consistently identified as important by the different 
machine learning modeling approaches. They are thus 
highly likely to represent true sources of predictive informa-
tion about the underlying pathology, echocardiographic 
LVH. These included limb lead parameters (R wave in lead I) 
and parameters involving the duration of ventricular activ-
ity (such as mean QT interval and mean QRS duration). This 
suggests that electrical manifestations of LVH go beyond 
anteriorly directed depolarization forces in the precordial 
leads, but also involve abnormalities in depolarization and 
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Figure 1. Composite plots of receiver operating characteristic curves for classical and machine learning models. A. Receiver operating 
characteristic plots for classical criteria (continuous). b. Receiver operating characteristic plots for classical criteria (thresholds). C. Receiver 
operating characteristic plots for machine learning models (with electrocardiogram parameters only). d. Receiver operating characteristic 
plots for machine learning models (with all predictive parameters)
repolarization. The left laterally directed depolarization 
forces may also be better represented by lead I, rather than 
the traditional precordial leads (such as V5–V6). 
When trained on all available predictive parameters, the 
machine learning models were also able to integrate non-
ECG data into their predictions, as evidenced by weight 
and body fat percentage being important variables iden-
tified. This suggests that the algorithms were able to learn 
adjustments for body habitus, an important factor that is 
not taken into account by classical models, but which prior 
studies have shown to improve diagnostic accuracy once 
included [24–26]. It is known that a person’s habitus can 
affect the sensitivity and specificity of classical ECG criteria, 
and this is one factor that limits the accuracy of classical 
ECG criteria [27]. However, it is notable that the machine 
learning models which integrated non-ECG data had similar 
performance to those including ECG parameters only. This 
suggests that the machine learning algorithms are able 
to infer some of information about body habitus from the 
other ECG parameters, and that our models can still be 
applied even in cases where anthropometric information 
is not available.
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A study by Kwon et al. [15] in an adult hospital cohort 
used a neural network based approach to improve on 
classical ECG criteria, with the best model (ensemble neu-
ral network) having an AUC of 0.868. Neural networks are 
a machine learning method which can accept unstructured 
data, such as an unprocessed ECG signal. They are able to 
use intensive computing methods to utilize information 
available in the signal that is not captured by conven-
tional ECG parameters, but conversely, may be difficult to 
interpret (i.e. more ”black-box”) because the contributing 
information is not pre-defined as a parameter. In contrast, 
our study was done on a screening pre-participation co-
hort, and used machine learning methods which accepted 
only predefined parameters measured from the ECG, thus 
finding the most optimal ways that they could be mathe-
matically combined. This approach also allowed identifica-
tion of the most important conventional ECG parameters, 
for easier interpretability. Although we had a different 
approach, the best model in our study (GLMNet) achieved 
a comparable AUC of 0.873. We believe that both strategies 
are equally valid, and that combined strategies may be able 
to achieve further gains in predictive performance. 
Strengths and limitations
The strength of our study is its large sample size, utilizing 
the data of 17  310 subjects. Furthermore, our dataset 
contained anthropometric variables, including body fat 
percentage, which are seldom collected systematically. 
However, we acknowledge that our study was performed in 
a pre-participation screening cohort, with a low incidence 
of actual LVH. The low number of true cases will limit gains 
to predictive accuracy, as subtle differences between true 
cases and controls will be harder to detect [28]. Further 
data collection with more pathological cases will help to 
increase the robustness of machine learning algorithms 
in this context.
Table 2. Area under receiver operating characteristic curve (AUC) of classical criteria and machine learning models
Predictive model AuC (95% CI)
Classical criteria (continuous) Sokolow–Lyon 0.629 (0.581–0.676)
Cornell 0.599 (0.549–0.650)
Cornell product 0.625 (0.575–0.675)
Romhilt–Estes 0.582 (0.536–0.628)
Classical criteria (thresholds) Sokolow–Lyon 0.589 (0.548–0.630)
Cornell 0.562 (0.529–0.596)
Cornell product 0.591 (0.552–0.629)
Romhilt–Estes 0.544 (0.503–0.585)
Machine learning models  
(with electrocardiogram parameters only)
Logistic Regression 0.811 (0.738–0.884)
GLMNet 0.873 (0.817–0.929)
Random Forests 0.824 (0.749–0.898)
Gradient Boosting Machines 0.800 (0.738–0.862)
Machine learning models  
(with all predictive parameters)
Logistic Regression 0.815 (0.745–0.885)
GLMNet 0.864 (0.804–0.924)
Random Forests 0.826 (0.756–0.897)
Gradient Boosting Machines 0.793 (0.723–0.863)
Table 3. Table of important predictive variables for each machine learning model
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Our study was performed exclusively in males, and 
there may be sex-specific differences in ECG-derived 
parameters or anthropometric findings. Further studies 
can be performed in populations of both sexes, but we 
believe that the techniques will be similarly applicable. We 
also recognize that CMRI derived LVH is the gold standard 
of diagnosis [29], whereas we used echocardiography 
to diagnose LVH. It is possible that classical criteria may 
perform better with CMRI as a diagnostic endpoint, as 
recent literature has showed that novel combinations of 
classical criteria can have good discriminatory power for 
CMRI derived LVH [30]. Nevertheless, this provides insight 
into the possibility of performing a similar analysis with 
CMRI data in the future.
One other potential limitation is that machine learning 
algorithms are by nature less interpretable than traditional 
predictive models [31]. Although it is possible to determine 
which variables are of importance to the algorithm, the 
underlying mathematical relationship to other variables is 
difficult to elucidate. This makes it challenging to check for 
problems such as overfitting [32]. Steps may be taken to 
guard against this, such as cross validation and separation 
of training and test sets [33, 34]. However, classical meth-
ods involving regression are just as susceptible to similar 
statistical problems, and are more likely to oversimplify the 
relationship between the variables. In general, all statistical 
models cannot determine the underlying pathophysiolog-
ical reasons that make a variable predictive for pathology. 
For the novel predictive variables identified by our machine 
learning models, further studies will be needed to elucidate 
the underlying mechanism.
Future work
The gains in predictive accuracy found in our cohort using 
machine learning models should be validated in other 
large, external cohorts. It is possible that the novel pa-
rameters identified by our cohort will have applicability in 
older adults as well, and this may be explored by clinicians 
managing other cohorts where LVH prediction is clinically 
important, such as older adults, hypertensive patients and 
patients with cardiomyopathy. 
Current consensus criteria recommend against the 
use of classical ECG criteria in determination of LVH from 
pre-participation ECGs [35], because their poor perfor-
mance can lead to unnecessary investigation or exclusion 
from physical activities. However, no alternative criteria ex-
ists, and this may conversely lead to underdiagnosis of true 
LVH. More accurate machine learning models developed 
in this study suggest a renewed role for ECG detection of 
LVH, which can contribute to safer recommendations for 
pre-participation screening
CONCluSIONS
Classical ECG criteria perform poorly in our young, pre-par-
ticipation cohort with a low prevalence of LVH. Machine 
learning methods show superior predictive performance 
and accord high importance to less recognized predictors 
of LVH from ECG. Addition of anthropometric data did not 
improve performance of machine learning models. Further 
research is required to improve the predictive ability of 
machine learning models, to implement these models in 
clinical care, and to understand the underlying pathology 
of the novel ECG predictors identified. 
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Supplementary material is available at https://journals.
viamedica.pl/kardiologia_polska.
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